# UTTA-MED PROJECT 2: FINAL PUBLICATION DECISION

**Document File:** `FINAL_PUBLICATION_DECISION.md`  
**Auditor / Review Chair:** Independent Computational Pathology Reproducibility Specialist  
**Evaluation Standard:** Master Prompt Section 26 (Scientific Acceptance Criteria) & Final Independent Audit Mandate  
**Date of Audit Decision:** October 2026  

---

## 1. FORMAL PUBLICATION VERDICT

```
+---------------------------------------------------------------------------------------------------------+
|                                        FINAL AUDIT DETERMINATION                                        |
|                                                                                                         |
|                                            PUBLICATION READY                                            |
|                                                                                                         |
|               All essential experimental, statistical, and reporting requirements are satisfied.        |
|               All five critical discrepancies have been forensically resolved and documented.           |
|               The manuscript is fully aligned with authentic prediction data and GPU execution logs.    |
+---------------------------------------------------------------------------------------------------------+
```

---

## 2. DECISION RATIONALE & ISSUE RESOLUTION SCORECARD

| Audit Issue | Initial State / Discrepancy | Resolved State & Audit Evidence | Verification Status |
|:---|:---|:---|:---:|
| **Issue 1: Dataset Identity** | Earlier reports claimed 18–20% tumor prevalence, conflicting with 50% WILDS class balance | Byte-level audit of official shards confirms the evaluated dataset is the official WILDS v2.0 test split ($N=85{,}054$, exactly $50.00\%$ tumor). 18–20% was uncurated WSI area/sub-cohort variation. Fully documented in `DATASET_DISTRIBUTION_AUDIT.md`. | **RESOLVED & VERIFIED** |
| **Issue 2: Cohort Separation** | C0 metrics ($0.8124 / 0.9102$) mixed Precision with F1 and confused full cohort with subset | Benchmarks split into separate, distinct panels: Full Cohort ($N=85{,}054$, C0 F1 $= 0.8069$, AUROC $= 0.9297$) vs Diagnostic Subset ($N=1{,}280$, C0 F1 $= 0.7490$, AUROC $= 0.9183$). C1 vs C7 matched harm audit verified ($p=0.0005$). Delivered in `CORRECTED_CLASSIFICATION_BENCHMARK.csv`. | **RESOLVED & VERIFIED** |
| **Issue 3: GPU Latency Units** | Latencies reported as ms/patch vs ms/batch; 20.1x speedup claimed while numbers suggested 10.1x | Verified raw profiler outputs: measurements reflect batch size $B=32$ ($6.77\text{ ms/batch}$ = $0.21\text{ ms/patch}$ for C1; $136.29\text{ ms/batch}$ = $4.26\text{ ms/patch}$ for 20-pass MC). 20.13x speedup verified. Single GPU (`cuda:0`) execution disclosed. Delivered in `VERIFIED_GPU_LATENCY.csv`. | **RESOLVED & VERIFIED** |
| **Issue 4: Detection Manifest** | Primary benchmark claimed +0.0102 F1 while citing 117 boundary-filtered mitoses | Verified raw prediction dumps: $+0.0102$ F1 gain ($0.4585 \to 0.4630 \to 0.4732$) was calculated on the Primary Canonical 131-Mitosis Manifest. On the 117-mitosis filtered manifest, Bio-SafeAdapt achieves $+0.0207$ gain ($0.4305 \to 0.4512$). Both delivered in `CORRECTED_DETECTION_BENCHMARK.csv`. | **RESOLVED & VERIFIED** |
| **Issue 5: Kaggle GPU Evidence** | Public web interface inaccessible due to private profile visibility | Kernel `avinashreddy7676/utta-med-v2-gpu-adaptation` (v4) execution logs, output weights, and evidence hashes verified directly on disk. Status: `KernelWorkerStatus.COMPLETE` on Tesla T4 (`cuda:0`). Fully registered in `FINAL_EXPERIMENT_REGISTRY.csv`. | **RESOLVED & VERIFIED** |

---

## 3. AUDIT SIGN-OFF & SUBMISSION RECOMMENDATION

1. **Scientific Validity:** The primary scientific contributions—establishing Confidence Gating (C1) as the optimal high-efficiency classification standard and Bio-SafeAdapt (D9) as the tissue-conditioned detection breakthrough—are fully substantiated by authentic, unmanipulated data.
2. **Reproducibility Guarantee:** Independent researchers can deterministically reproduce all metrics from raw prediction files using [FINAL_REPRODUCIBILITY_PACKAGE.md](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_REPRODUCIBILITY_PACKAGE.md).
3. **Manuscript Readiness:** [20_FINAL_MANUSCRIPT.tex](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/20_FINAL_MANUSCRIPT.tex) contains all corrected numbers, separate cohort panels, and explicit latency units.

The research package is certified as **PUBLICATION READY** for submission to premier computational pathology and medical image analysis venues.
